Back
 OJU  Vol.3 No.1 , February 2013
Can the Rectum Balloon Minimize Rectal Toxicity During Irradiation Therapy of Prostate Cancer?
Abstract: The irradiation of the rectum cancer occurs in many institutes by using a rectum balloon in order to reduce the mobility of the target organ and to distance the rectum from the target organ. The objective is to reduce side effects quantitatively as well as qualitatively. On the basis of two hospitals using identical techniques for the prostate irradiation with the sole difference of the rectum balloon the toxicity has been evaluated with the result of no significant difference between the cohorts concerning diarrhea, rectal pain symptoms and rectal bleedings. Therefore the authors consider the use of the rectum balloon prior to each irradiation not necessary for the reduction of toxicity particularly due to the fact that the application is often very painful, especially for patients with hemorrhoids. The rectum balloon as a tool for the reduction of the prostate mobility was not objective of this study.
Cite this paper: N. Landwehr, M. Georg Krukemeyer and W. Wagner, "Can the Rectum Balloon Minimize Rectal Toxicity During Irradiation Therapy of Prostate Cancer?," Open Journal of Urology, Vol. 3 No. 1, 2013, pp. 37-43. doi: 10.4236/oju.2013.31007.
References

[1]   G. E. Hanks, K. I. Martz and J. J. Diamond, “The Effect of Dose on Local Control of Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 15, No. 6, 1988, pp. 1299-1305. doi:10.1016/0360-3016(88)90224-6

[2]   G. E. Hanks, T. E. Schultheiss, M. Hunt and B. Epstein, “Factors Influencing Incidence of Acute Grade 2 Morbidity in Conformal and Standard Radiation Treatment of Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 31, No. 1, 1995, pp. 25-29. doi:10.1016/0360-3016(94)00366-S

[3]   G. E. Hanks, A. L. Hanlon, W. Pinover, E. Horwitz and T. Schultheiss, “Dose Selection for Prostate Cancer Patients Based on Dose Comparison and Dose Response Studies,” International Journal of Radiation Oncology, Biology, Physics, Vol. 57, No. 2, 2000, pp. 384-390.

[4]   S. Levegrun, A. Jackson, M. Zelefsky, et al., “Analysis of Biopsy Outcome after Three-Dimensional Conformal Radiation Therapy of Prostate Cancer Using Dose-Distribution Variables and Tumor Control Probability Models,” International Journal of Radiation Oncology, Biology, Physics, Vol. 47, No. 5, 2000, pp. 1245-1260. doi:10.1016/S0360-3016(00)00572-1

[5]   A. Pollack, G. K. Zagars, L. G. Smith, H. Lee, et al., “Preliminary Results of a Randomized Radiotherapy, Dose-Escalation Study Comparing 70 Gy with 78 Gy for Prostate Cancer,” Journal of Clinical Oncology, Vol. 18, No. 23, 2000, pp. 3904-3911.

[6]   Z. Symon, K. A. Griffith, P. W. Laughlin, et al., “Dose Escalation for Localized Prostate Cancer: Substantial Benefit Observed with 3-D-Conformal Therapy,” International Journal of Radiation Oncology, Biology, Physics, Vol. 57, No. 2, 2003, pp. 384-390. doi:10.1016/S0360-3016(03)00569-8

[7]   R. Valicenti, J. Lu, M. Pipepich and D. Grignon, “Survival Advantage from Higher-Dose Radiation Therapy for Clinically Localized Prostate Cancer Treated on the Radiation Therapy Oncology Group Trials,” Journal of Clinical Oncology, Vol. 18, No. 14, 2000, pp. 2740-2746.

[8]   M. J. Zelefsky, Z. Fuks, M. Hunt, et al, “High-Dose Intensity Modulated Radiation Therapy for Prostate Cancer: Early Toxicity and Biochemical Outcome in 722 Patients,” International Journal of Radiation Oncology, Biology, Physics, Vol. 53, No. 5, 2002, pp. 1111-1116. doi:10.1016/S0360-3016(02)02857-2

[9]   P. A. Kupelian, L. Potters, D. Khuntia, et al., “Radical Prostatectomy, External Beam Radiotherapy <72Gy, External Beam Radiotherapy <72 Gy, Permanent Seed Implantation or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 58, No. 1, 2004, pp. 25-33. doi:10.1016/S0360-3016(03)00784-3

[10]   P. A. Kupelian, M. Elshaikh, Ch. Reddy, C. Zippe and E. A. Klein, “Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience with Radical Prostatectomy and External-Beam Radiotherapy,” Journal of Clinical Oncology, Vol. 20, No. 16, 2002, pp. 3376-3385. doi:10.1200/JCO.2002.01.150

[11]   L. Potters, E. A. Klein, M. W. Kattan, P. A. Kupelian, et al., “Monotherapy for Stage T1-T2 Prostate Cancer: Radiacal Prostatectomy, External Beam Radiotherapy or Permanent Seed Implantation,” Radiotherapy & Oncology, Vol. 71, No. 1, 2004, pp. 29-33. doi:10.1016/j.radonc.2003.12.011

[12]   D. B. Chism, E. Horwitz, A. Hanlon, W. Pinover, et al., “Late Morbidity Profile in Prostate Cancer Patients Treated to 79-84 Gy by a Simple Four-Field Coplanar Beam Arrangement,” International Journal of Radiation Oncology, Biology, Physics, Vol. 55, No. 1, 2003, pp. 71-77. doi:10.1016/S0360-3016(02)03822-1

[13]   C. Fiorino, C. Cozzarini, V. Vavassori, G. Sanguinetti, et al., “Relationships between DVHs and Late Rectal Bleeding after Radiotherapy for Prostate Cancer: Analysis of a Large Group of Patients Pooled from Three Institutions,” Radiotherapy & Oncology, 64, No. 1, 2002, pp. 1-12. doi:10.1016/S0167-8140(02)00147-0

[14]   E. H. Huang, A. Pollack, L. Levy, et al., “Late Rectal Toxicity: Dose-Volume Effects of Conformal Radiotherapy for Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 54, No. 5, 2002, pp. 1314-1321. doi:10.1016/S0360-3016(02)03742-2

[15]   A. Jackson, M. W. Skwarchuk, M. Zelefsky, et al., “Late Rectal Bleeding after Conformal Radiotherapy of Prostate Cancer (II): Volume Effects and Dose-Volume Histograms,” International Journal of Radiation Oncology, Biology, Physics, Vol. 49, No. 3, 2001, pp. 685-698. doi:10.1016/S0360-3016(00)01414-0

[16]   J. M. Michalski, J. A. Purdy, K. Winter, M. Roch III, et al., “Preliminary Report of Toxicity Following 3-D-Radiation Therapy for Prostate Cancer on 3 DOG/RTOG 9406,” International Journal of Radiation Oncology, Biology, Physics, 46, No. 2, 2000, pp. 391-402. doi:10.1016/S0360-3016(99)00443-5

[17]   S. T. Peeters, W. Heemsbergen, W. L. J. Putten, et al., “Acute and Late Complications after Radiotherapy for Prostate Cancer: Results of a Multicenter Randomized Trial Comparing 68 Gy to 78 Gy,” International Journal of Radiation Oncology, Biology, Physics, Vol. 61, No. 4, 2005, pp. 1019-1034. doi:10.1016/j.ijrobp.2004.07.715

[18]   G. E. Hanks, Al. Hanlon, B. Epstein and E. Horwitz, “Dose Response in Prostate Cancer with 8 - 12 Years’ Follow-Up,” International Journal of Radiation Oncology, Biology, Physics, Vol. 54, No. 2, 2002, pp. 427-435. doi:10.1016/S0360-3016(02)02954-1

[19]   G. J. Kutcher and C. Burman, “Calculation of Complication Probability Factors for Non-Uniform Normal Tissue Irradiation: The Effective Volume Method,” International Journal of Radiation Oncology, Biology, Physics, Vol. 16, No. 6, 1989, pp. 1623-1630. doi:10.1016/0360-3016(89)90972-3

[20]   A. V. D′Amico, J. Manola, M. Loffredo, et al., “A Practical Method to Achieve Prostate Gland Immobilization and Target Verification for Daily Treatment,” International Journal of Radiation Oncology, Biology, Physics, Vol. 51, No. 5, 2001, pp. 1431-1436. doi:10.1016/S0360-3016(01)02663-3

[21]   N. Gerstner, St. Wachter, D. Dorner, et al., “A Rectal Balloon Catheter as Internal Immobilization Device for Conformal Radiotherapy of Prostate Cancer,” Strahlentherapie und Onkologie, 175, No. 5, 1999, pp. 232-238. doi:10.1007/BF02742401

[22]   R. J. Smeenk, R. J. Louwe, K. M. Langen, et al., “An Endorectal Balloon Reduces Intrafraction Prostate Motion During Radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, 1; Vol. 83, No. 2, 2012, pp. 661-669.

[23]   B. S. Teh, W. Y. Mai, B. Uhl, et al., “Intensity-Modulated Radiation Therapy (IMRT) for Prostate Cancer with the Use of a Rectal Balloon for Prostate Immobilization: Acute Toxicity and Dose-Volume Analysis,” International Journal of Radiation Oncology, Biology, Physics, Vol. 49, No. 3, 2001, pp. 705-712. doi:10.1016/S0360-3016(00)01428-0

[24]   S. Wachter, N. Gerstner, K. Dieckmann, et al., “Three Dimensional Planned Conformal Low Volume Radiotherapy of Localized Carcinoma of the Prostate,” Strahlentherapie und Onkologie, Vol. 173, No. 5, 1997, pp. 253-260. doi:10.1007/BF03039434

[25]   M. J. Ghilezan, A. D. Jaffray, J. H. Siewerdsen, et al., “Prostate Gland Motion Assessed with Cine-Magnetic Resonance Imaging (Cine-MRJ),” International Journal of Radiation Oncology, Biology, Physics, Vol. 62, No. 2, 2005, pp. 406-417. doi:10.1016/j.ijrobp.2003.10.017

[26]   E. Van Lin, L. P. van der Vight, et al., “The Effect of an Endorectal Balloon and Off-Line Correction on the Interfraction Systematic and Random Prostate Position Variations: A Comparative Study,” International Journal of Radiation Oncology, Biology, Physics, Vol. 61, No. 1, 2005, pp. 278-288. doi:10.1016/j.ijrobp.2004.09.042

[27]   A. Y. Hung, M. Garzotto and D. Kaurin, “Minimal Benefit of an Endorectal Balloon for Prostate Immobilization as Verified by Daily Localization,” Medical Dosimetry, Vol. 36, No. 2, pp. 195-199. doi:10.1016/j.meddos.2010.03.003

[28]   C. W. Wang, F. C. Chong, M. K. Lai, Y. S. Pu, et al., “Set-Up Errors Due to Endorectal Balloon Positioning in Intensity Modulated Radiation Therapy for Prostate Cancer,” Radiotherapy & Oncology, Vol. 84, No. 2, 2007, pp. 177-184. doi:10.1016/j.radonc.2007.06.009

[29]   S. Both, K. K. Wang, J. P. Plastaras, et al., “Real-Time Study of Prostate Intrafraction Motion during External Beam Radiotherapy with Daily Endorectal Balloon,” International Journal of Radiation Oncology, Biology, Physics, Vol. 81, No. 5, 2011, pp. 1302-1309.

[30]   B. S. Teh, L. Dong, J. E. Me Gary, et al., “Rectal Wall Sparing by Dosimetric Effect of Rectal Balloon Used during Intensity-Modulated Radiation Therapy (IMRT) for Prostate Cancer,” Medical Dosimetry, Vol. 30, No. 1, 2005, pp. 25-30. doi:10.1016/j.meddos.2004.10.005

[31]   K. Takayama, T. Mizowaki, Y. Negoro, et al., “Impact of Double-Balloon Rectal Catheter Use in External-Beam Radiotherapy for Prostate Cancer,” International Journal of Clinical Oncology, Vol. 16, No. 1, 2011, pp. 50-56. doi:10.1007/s10147-010-0129-7

[32]   A. L. Hartford, A. Niemierko, J. A. Adams, M. M. Urie, W. Shipley, et al., “Conformal Irradiation of the Prostate Estimating Long-Term Rectal Bleeding Risk Using Dose-Volume Histograms,” International Journal of Radiation Oncology, Biology, Physics, Vol. 36, No. 3, 1996, pp. 721-730. doi:10.1016/S0360-3016(96)00366-5

[33]   R. Patel, N. Orton, W. A. Tome, et al., “Rectal Dose Sparing with Balloon Catheter and Ultrasound Localization in Conformal Radiation Therapy for Prostate Cancer,” Radiotherapy & Oncology, Vol. 67, No. 3, 2003, pp. 285-294. doi:10.1016/S0167-8140(03)00056-2

[34]   M. V. Sanghani, J. Ching, D. Schultz, et al., “Impact on Rectal Dose from the Use of a Prostate Immobilization and Rectal Localization Device for Patients Receiving Dose Escalated 3-D-Conformal Radiation Therapy,” Urologic Oncology, Vol. 22, No. 3, 2004, pp. 165-168. doi:10.1016/j.urolonc.2004.02.002

[35]   R. J. Smeenk, E. N. van Lin, P. van Kollenburg, et al., “Endorectal Balloon Reduces Anorectal Doses in Post-Prostatectomy Intensity-Modulated Radiotherapy,” Radiotherapy & Oncology, Vol. 101, No. 3, 2011, pp. 465-470. doi:10.1016/j.radonc.2011.07.019

[36]   H. Geinitz, F. B. Zimmermann, L. Narkwong, et al., “Prostate Cancer: Difficulties Regarding the Interpretation of Rectal Dose-Volume Histograms,” Strahlentherapie und Onkologie, Vol. 176, No. 4, 2000, pp. 168-172. doi:10.1007/s000660050052

[37]   L. J. Boersma, M. van den Brin, A. M. Bruce, T. Shouman, et al., “Estimation of the Incidence of Late Bladder and Rectum Complications after High-Dose (70-78 Gy) Conformal Radiotherapy for Prostate Cancer Using Dose-Volume Histograms,” International Journal of Radiation Oncology, Biology, Physics, Vol. 41, No. 1, 1998, pp. 83-92. doi:10.1016/S0360-3016(98)00037-6

[38]   H. Elshaved, T. B?lling, C. Moustakis, et al., “Organ Movements and Dose Exposures in Teletherapy Of Prostate Cancer Using a Rectal Balloon,” Strahlentherapie und Onkologie, Vol. 183, No. 11, 2007, pp. 617-624. doi:10.1007/s00066-007-1736-8

[39]   C. Vargas, A. Martinez, L. L. Kerstin, et al., “Dose-Volume Analysis of Predictors for Chronic Rectal Toxicity after Toxicity after Treatment of Prostate Cancer with Adaptive Image-Guided Radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, Vol. 62, No. 5, 2005, pp. 1297-1308. doi:10.1016/j.ijrobp.2004.12.052

[40]   F. Paulson, C. Belka, M. Alber, W. Budach and M. Bamberg, “Intensity Modulated Radiotherapy IMRT,” Onkologe, Vol. 9, No. 3, 2003, pp. 315-327. doi:10.1007/s00761-003-0495-0

 
 
Top